@inproceedings{inproceedings, title  = {{LONG-TERM EFFICACY AND SAFETY OF DUPILUMAB IN A PHASE 3 OPEN-LABEL EXTENSION TRIAL (LIBERTY AD PED-OLE) IN PATIENTS AGED >= 6 TO < 12 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS}},

 url = {{}},

 year = {{2021}},

 month = {{1}},

 author = {{Cork MJ and Thaci D and Eichenfield LF and Arkwright PD and Chen Z and Prescilla R and Delevry D and O'Malley JT and Bansal A}},

 volume = {{101}},

 journal = {{ACTA DERMATO-VENEREOLOGICA}},

 pages = {{60-60}},

 note = {{Accessed on 2024/12/22}}}